Autori: Samarzija Miroslav
| Naslov | Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan. (Meeting Abstract) |
| Autori | Hart Lowell L Andric Zoran G ... Radosavljevic Davorin Z Jovanovic Dragana ... Samarzija Miroslav Zaric Bojan ... (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. (Meeting Abstract) |
| Autori | Ramalingam Suresh S Zaric Bojan Ceric Timur ... Samarzija Miroslav ... Vukovic Vojislav M (broj koautora 20) |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2014), vol. 32 br. 15, Suppl. S, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science |
